✦ LIBER ✦

Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study

✍ Scribed by Takafumi Ichida; Masashi Kato; Akihito Hayakawa; Masashi Watanabe; Kentaro Igarashi; Koujiro Hata; Yasuyuki Doya; Masahiko Miura; Hiroshi Sato; Hitoshi Asakura

Book ID: 104887446
Publisher: Springer
Year: 1992
Tongue: English
Weight: 739 KB
Volume: 31
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00687105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of unresectable hepatocellular

Treatment of unresectable hepatocellular carcinoma with alpha-2B interferon and adriamycin. Final results of a pilot study

✍ Grangé, JD; Lotz, JP; Amiot, X; Lamarque, D; Hannoun, L; Parc, R; Bodin, F; Izra 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Effects of the combined treatment with t

Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma: A pilot study

✍ F. Mirici Cappa; M.C. Cantarini; G. Magini; A. Zambruni; C. Bendini; V. Santi; M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Prospective and randomized clinical tria

Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma — a comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study)

✍ Saburo Kawai; Jun Okamura; Makoto Ogawa; Yasuo Ohashi; Masayoshi Tani; Jushiro I 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 553 KB

A phase II study of chronomodulated (CHR

A phase II study of chronomodulated (CHR) 5-fluorouracil (5-FU) and leucovorin (LV) in combination with epirubicin (EPIDX)and Cis-Platin (CDDP) in the treatment of metastatic gastric carcinoma (MGC)

✍ Bertuccelli, M.; Falcone, A.; Brunetti, I.; Pfanner, E.; Allegrini, G.; Panduri, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 265 KB

The effect of menatetrenone, a vitamin K

The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment : A pilot study

✍ Toshihiko Mizuta; Iwata Ozaki; Yuichiro Eguchi; Tsutomu Yasutake; Seiji Kawazoe; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

AOSOP3 Combination of bevacizumab and er

AOSOP3 Combination of bevacizumab and erlotinib in the treatment of patients with advanced hepatocellular carcinoma with sorafenib-refractory disease: Results of a pilot phase II study

✍ T. Yau; H. Wong; P. Chan; T.J. Yao; T.T. Cheung; S.T. Fan; R.T. Poon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 151 KB